Women

Premier source for advice and insights focused on women's health

  • Providence Everett Honored for Excellence in Maternity Care

    Providence Everett Honored for Excellence in Maternity Care

    U.S. News & World Report named Providence Regional Medical Center Everett (PRMCE) a 2025 High Performing Hospital for Maternity Care.

    Read Article
  • A year to remember: Advancements, recognition and transitions

    A year to remember: Advancements, recognition and transitions

    Catch the 2024 highlights from Providence Cancer Institute in this year-end recap focused on research advancements, caregiver recognition and community engagement.

    Read Article
  • CAR T cell-therapy, hope and healing: Dean’s story

    CAR T cell-therapy, hope and healing: Dean’s story

    Discover how Dean Lookingbill’s battle with lymphoma led him to CAR T-cell therapy at Providence Cancer Institute.

    Read Article
  • Providence Swedish North offers free STOP THE BLEED® training

    Providence Swedish North offers free STOP THE BLEED® training

    Providence Swedish North is offering free STOP THE BLEED® training at Providence Regional Medical Center Everett.

    Read Article
  • Harnessing CAR T-cell therapy: A new study for indolent B-cell non-Hodgkin lymphoma

    Harnessing CAR T-cell therapy: A new study for indolent B-cell non-Hodgkin lymphoma

    New study evaluates a type of CAR T-cell therapy called liso-cel. Researchers will collect data from multiple groups in a study that may give patients hope for long-term remission and quality of life.

    Read Article
  • New studies test immunotherapy to boost breast cancer treatment and prevent return

    New studies test immunotherapy to boost breast cancer treatment and prevent return

    Explore promising clinical trials at Providence Cancer Institute that are investigating immunotherapy for early-stage TNBC and high-risk, HR-positive breast cancer.

    Read Article
  • Attend a free virtual symposium on melanoma, Oct. 25

    Attend a free virtual symposium on melanoma, Oct. 25

    Providence Cancer Institute in partnership with AIM at Melanoma present a free online event designed to educate and empower patients and care partners affected by melanoma.

    Read Article
  • GET THE APP ›
  • Understanding seasonal affective disorder (SAD)

    Understanding seasonal affective disorder (SAD)

    Don’t get SAD. An expert at Providence answers common questions to help you understand seasonal affective disorder.

    Read Article
  • Providence Swedish earns national recognitions from American Heart Association

    Providence Swedish earns national recognitions from American Heart Association

    The awards highlight Providence Swedish's consistency in following the American Heart Association's guidelines for care, treatment and improved outcomes in stroke and diabetes.

    Read Article
  • Navigating your journey through menopause

    Navigating your journey through menopause

    Menopause is a natural aging process for roughly half the population. Learn how to navigate the journey from perimenopause to menopause and beyond.

    Read Article
  • 2024 Hood to Coast Relay: Providence team captains tell us why they run

    2024 Hood to Coast Relay: Providence team captains tell us why they run

    What motivates the co-captains of the FINISHCANCER caregiver team to commit their time to running this remarkable relay? Read what they say about preparing for the race and what inspires them to run.

    Read Article
  • FIND A CLINIC ›
  • Providence Community Cancer Screening Event

    Providence Community Cancer Screening Event

    Providence Community Cancer Screening Event

    Read Article
  • Targeting cancer cells: Two studies take different approaches

    Targeting cancer cells: Two studies take different approaches

    A study designed to treat recurrent epithelial ovarian cancer looks at an antibody drug conjugate, and a second study for people with advanced breast cancer evaluates a drug that degrades estrogen rec

    Read Article
  • The evolution of cancer immunotherapy: Dr. Urba shares his insights

    The evolution of cancer immunotherapy: Dr. Urba shares his insights

    Providence Cancer Institute chief medical officer Walter J. Urba, M.D., Ph.D. talks about the evolution of immunotherapy in the past three decades and his vision for its future.

    Read Article
  • Cancer survivorship: A guide to living with and beyond cancer

    Cancer survivorship: A guide to living with and beyond cancer

    June is National Cancer Survivor Month, but we honor people with cancer, no matter where they are on their journey, every day of the year. Find out about the survivorship program at Providence Cancer

    Read Article
  • Radiation oncologist discusses MRI-guided radiation therapy for pancreatic cancer

    Radiation oncologist discusses MRI-guided radiation therapy for pancreatic cancer

    Providence Cancer Institute presented a free virtual education event about MRI-guided radiation therapy and how it is used to treat pancreatic cancer.

    Read Article
  • Cancer studies seek to harness the power of the immune system

    Cancer studies seek to harness the power of the immune system

    Explore three innovative studies targeting uveal melanoma, melanoma and head and neck squamous cell carcinoma. Learn why these studies offer hope for more effective cancer treatments.

    Read Article
  • Celebrating World Immunology Day

    Celebrating World Immunology Day

    Providence Cancer Institute researcher shares her journey to immunology and the advice she has for those seeking a career in cancer research.

    Read Article
  • Providence St. Joseph Hospital in Orange officially opens the Helen Caloggero Women’s and Family Center

    Providence St. Joseph Hospital in Orange officially opens the Helen Caloggero Women’s and Family Center

    Sprawling multi-million dollar facility in Orange County is a one-stop location to access full-suite of women’s health, mother-baby services and more

    Read Article
  • New vaccine being studied for HPV+ head and neck cancer

    New vaccine being studied for HPV+ head and neck cancer

    Researchers at Providence Cancer Institute are exploring a range of innovative approaches to targeting human papillomavirus-positive head and neck squamous cell cancer.

    Read Article
  • loading
    Loading More...